Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim J Hagan

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|June 11, 2004
Urotensin-II, a neuropeptide ligand for GPR14, induces c-fos in the rat brainJane E Gartlon, Tracey Ashmeade, Mark Duxon, et al.
Synapse (New York, N.Y.)|February 3, 2004
Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological studyYoshio Minabe, Yukihiko Shirayama, Kenji Hashimoto, et al.
Brain Research|May 30, 2006
Long-lasting changes in behavioural and neuroendocrine indices in the rat following neonatal maternal separation: gender-dependent effectsHelge A Slotten, Mikhail Kalinichev, Jim J Hagan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 15, 2003
Selective antagonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortexLaurent P Lacroix, Mark E P Hows, Ajit J Shah, et al.
Brain Research. Brain Research Reviews|June 18, 2005
The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidenceChristian A Heidbreder, Eliot L Gardner, Zheng-Xiong Xi, et al.
Psychopharmacology|April 23, 2005
5-HT6 receptor antagonists improve performance in an attentional set shifting task in ratsPaula D Hatcher, Verity J Brown, David S Tait, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 2009
Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotypeHasib Salah-Uddin, Elizabeth Scarr, Geoffrey Pavey, et al.
Psychopharmacology|April 15, 2004
Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in ratsZheng-Xiong Xi, Jeremy Gilbert, Arlene C Campos, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 2008
Pharmacological assessment of m1 muscarinic acetylcholine receptor-gq/11 protein coupling in membranes prepared from postmortem human brain tissueHasib Salah-Uddin, David R Thomas, Ceri H Davies, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 23, 2003
The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged ratsAndrew G Foley, Keith J Murphy, Warren D Hirst, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|June 11, 2004
Urotensin-II, a neuropeptide ligand for GPR14, induces c-fos in the rat brainJane E Gartlon, Tracey Ashmeade, Mark Duxon, et al.
Synapse (New York, N.Y.)|February 3, 2004
Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological studyYoshio Minabe, Yukihiko Shirayama, Kenji Hashimoto, et al.
Brain Research|May 30, 2006
Long-lasting changes in behavioural and neuroendocrine indices in the rat following neonatal maternal separation: gender-dependent effectsHelge A Slotten, Mikhail Kalinichev, Jim J Hagan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 15, 2003
Selective antagonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortexLaurent P Lacroix, Mark E P Hows, Ajit J Shah, et al.
Brain Research. Brain Research Reviews|June 18, 2005
The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidenceChristian A Heidbreder, Eliot L Gardner, Zheng-Xiong Xi, et al.
Psychopharmacology|April 23, 2005
5-HT6 receptor antagonists improve performance in an attentional set shifting task in ratsPaula D Hatcher, Verity J Brown, David S Tait, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 2009
Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotypeHasib Salah-Uddin, Elizabeth Scarr, Geoffrey Pavey, et al.
Psychopharmacology|April 15, 2004
Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in ratsZheng-Xiong Xi, Jeremy Gilbert, Arlene C Campos, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 2008
Pharmacological assessment of m1 muscarinic acetylcholine receptor-gq/11 protein coupling in membranes prepared from postmortem human brain tissueHasib Salah-Uddin, David R Thomas, Ceri H Davies, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 23, 2003
The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged ratsAndrew G Foley, Keith J Murphy, Warren D Hirst, et al.
Pageof 4